How do you ensure the stability of the hybridoma cell line after domestication?

We prioritize cell line stability through rigorous selection and subcloning. Throughout adaptation, we monitor for changes in growth rate and antibody production, selecting only the most robust and consistent clones. We carry out numerous rounds of limited dilution subcloning to minimize genetic drift and guarantee sustained antibody production.

What cell densities and viability do you guarantee post-thaw for cryopreserved cell lines?

To maximize post-thaw cell viability, we use optimized cryopreservation protocols with effective cryoprotective agents. While exact values vary, our general target is 80% or higher post-thaw viabilities. We aim for cell densities that support immediate culture initiation or expansion. Each cryopreserved batch undergoes thorough quality control testing to ensure these standards are met.

How do you handle cell lines with low viability prior to domestication?

For hybridoma cell lines with low initial viability, particularly during hybridoma rescue, we use specialized techniques to enhance cell recovery. These may include enzymatic digestion, selective media with growth factors and anti-apoptotic agents, and optimized thawing protocols for frozen stocks. We closely monitor cells during initial recovery to support their survival and proliferation.

What are your criteria for a successful domestication?

We define successful domestication by achieving robust cell growth in serum-free suspension, maintaining high antibody production, and demonstrating cell line stability over multiple passages. Attaining target cell densities and viability after cryopreservation is also essential. We communicate closely with clients to define specific success criteria, providing regular monitoring and detailed reports.

What types of serum-free media do you use for the domestication process?

We use various high-quality, commercially available, and in-house developed serum-free media, selected based on each cell line's specific requirements. Media may be supplemented with growth factors and other additives. Our team optimizes media composition.

Can you provide any post-domestication support or optimization?

We offer comprehensive post-domestication support to ensure the successful integration of suspension-adapted cell lines. This includes assistance with scale-up, additional media optimization, and troubleshooting. We also guide bioreactor operation, including feeding strategies and downstream processing. Our team is committed to addressing your questions and providing ongoing support to help achieve your antibody production goals.

Hybridoma Suspension Domestication Service

Overview Service Features FAQ

As a leading provider of hybridoma services, Creative Biolabs has established a complete hybridoma suspension domestication system, specializing in seamless transition to serum-free suspension culture. With extensive experience and an established track record, we empower our clients with robust, high-performing cell lines. We bring to our customers cutting-edge technology, customized solutions, and dedicated support to accelerate their research and development.

Overview of Hybridoma Culture

Hybridoma cell culture in vitro is an important way for producing monoclonal antibodies (mAbs). Dulbecco's Modified Eagle's Medium (DMEM) and RPMI-1640 are the most frequently used basal media for hybridoma culture, typically supplemented with fetal bovine serum (FBS). Traditionally, serum supplementation has been essential for the long-term viability of cells in tissue culture. However, FBS and other animal-derived products often exhibit significant lot-to-lot variability in composition, including nutrient and vitamin content, and can harbor contaminants. Such inconsistencies substantially affect cell growth and antibody production, thereby complicating manufacturing processes. Moreover, FBS introduces contaminants that reduce the purity of mAbs.

Hybridoma cell suspension culture domestication is the process of adapting hybridoma cells to grow in suspension within a serum-free environment. However, the transition from adherent, serum-dependent cultures to serum-free suspension cultures can be a complex and demanding process. Hybridoma cells, which have evolved in a serum-rich environment, often struggle to adapt to the altered conditions. This adaptation can lead to reduced cell viability, decreased antibody production, and even cell death. Successful domestication requires careful optimization of culture conditions, including media composition, supplements, and physical parameters, to ensure the cells thrive and maintain their antibody-producing capabilities.

Hybridoma cell suspension cultures provide several advantages over traditional adherent cultures, including enhanced scalability, increased homogeneity, and simplified purification of the resulting monoclonal antibodies. Serum-free media are highly effective for culturing parental cells before fusion and for selecting hybridomas immediately after fusion. Besides, substituting serum-free alternatives for serum-containing media offers substantial ethical and scientific benefits, particularly for subsequent antibody purification.

Workflow of Our Hybridoma Suspension Domestication Service

We offer specialized services for hybridoma suspension and adaptation, enabling the revitalization of hybridoma cell lines and facilitating the rapid, large-scale production of antibodies. Our established protocols for hybridoma suspension adaptation allow cells to proliferate and express antibodies in serum-free media, thereby ensuring consistent antibody quality and eliminating potential animal virus contamination.

Fig.1 The process of hybridoma suspension domestication. (Creative Biolabs Original) Fig.1 Hybridoma suspension domestication workflow.

01 Initiation

We begin by assessing the starting hybridoma cell line, whether frozen or in culture, employing specialized techniques for maximum recovery. This initial assessment, crucial for determining the optimal revival strategy, evaluates cell viability, density, and contamination. For frozen stocks, we use rapid thawing and specialized media to minimize damage and promote quick recovery. For existing cultures, we assess the growth phase and overall health for optimal transition.

02 Adaptation

Cells are gradually weaned off serum-containing media and introduced to suspension culture. This step-wise approach minimizes stress, promoting cell survival. This critical transition involves progressive serum reduction and introduction to agitation, allowing cells to adapt their metabolism and morphology to the new environment, ensuring long-term viability and productivity.

03 Optimization

We optimize culture conditions—media composition, agitation speed, and other parameters—to enhance cell growth and antibody production in suspension. This optimization maximizes performance. We evaluate serum-free media, growth factors, and supplements to identify the optimal composition. Agitation speed is controlled for oxygenation and nutrient distribution, while minimizing shear stress. Other parameters like temperature and pH are fine-tuned for ideal cell growth and antibody production.

04 Screening

We rigorously screen adapted cells to identify the most viable and productive clones, performing subcloning to isolate stable, high-producing cell lines. This process isolates the best-performing clones from the heterogeneous cell population. We use flow cytometry, ELISA, and limiting dilution to assess viability, antibody titer, and monoclonality. Subcloning ensures genetically identical cells that consistently produce high levels of the desired antibody.

05 Storage

The final, suspension-adapted hybridoma cell lines are cryopreserved for long-term storage and future use, ensuring preservation of cell viability and antibody-producing capabilities. Cryopreservation is critical for future use and preventing genetic drift. We use controlled freezing protocols and cryoprotective agents to minimize damage. Post-thaw viability and antibody production are rigorously tested to ensure desired characteristics are retained.

Features of Our Service

Seamless transition from adherent to suspension culture for hybridoma cells
Customized protocols tailored to specific hybridoma cell lines
Enhanced cell viability and growth rates in suspension
Cutting-edge technology for ensuring consistent product quality from batch to batch
High affinity and good specificity of antibodies
Expert guidance and support throughout the domestication process

FAQ

Q: How do you ensure the stability of the hybridoma cell line after domestication?
A: We prioritize cell line stability through rigorous selection and subcloning. Throughout adaptation, we monitor for changes in growth rate and antibody production, selecting only the most robust and consistent clones. We carry out numerous rounds of limited dilution subcloning to minimize genetic drift and guarantee sustained antibody production.
Q: What cell densities and viability do you guarantee post-thaw for cryopreserved cell lines?
A: To maximize post-thaw cell viability, we use optimized cryopreservation protocols with effective cryoprotective agents. While exact values vary, our general target is 80% or higher post-thaw viabilities. We aim for cell densities that support immediate culture initiation or expansion. Each cryopreserved batch undergoes thorough quality control testing to ensure these standards are met.
Q: How do you handle cell lines with low viability prior to domestication?
A: For hybridoma cell lines with low initial viability, particularly during hybridoma rescue, we use specialized techniques to enhance cell recovery. These may include enzymatic digestion, selective media with growth factors and anti-apoptotic agents, and optimized thawing protocols for frozen stocks. We closely monitor cells during initial recovery to support their survival and proliferation.
Q: What are your criteria for a successful domestication?
A: We define successful domestication by achieving robust cell growth in serum-free suspension, maintaining high antibody production, and demonstrating cell line stability over multiple passages. Attaining target cell densities and viability after cryopreservation is also essential. We communicate closely with clients to define specific success criteria, providing regular monitoring and detailed reports.
Q: What types of serum-free media do you use for the domestication process?
A: We use various high-quality, commercially available, and in-house developed serum-free media, selected based on each cell line's specific requirements. Media may be supplemented with growth factors and other additives. Our team optimizes media composition.
Q: Can you provide any post-domestication support or optimization?
We offer comprehensive post-domestication support to ensure the successful integration of suspension-adapted cell lines. This includes assistance with scale-up, additional media optimization, and troubleshooting. We also guide bioreactor operation, including feeding strategies and downstream processing. Our team is committed to addressing your questions and providing ongoing support to help achieve your antibody production goals.

With deep understanding of hybridoma development, Creative Biolabs offers hybridoma suspension domestication service to help clients save valuable hybridoma clones and bring them back to good condition. If you are interested in our services, please feel free to contact us for more information.

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

	USA: Europe: Germany:
	Call us at: USA: UK: Germany:
	Fax:
	Email: